anafranil 25 mg
tzamal bio-pharma ltd - clomipramine hydrochloride - coated tablets - clomipramine hydrochloride 25 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.
fluvoxamine teva 50 mg
teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 50 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).
fluvoxamine teva 50 mg
teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 50 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).
fluvoxamine teva 100 mg
teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 100 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).
ebixa tablets 10 mg
lundbeck israel ltd. - memantine hydrochloride - film coated tablets - memantine hydrochloride 10 mg - memantine - memantine - treatment of patient with moderate to severe alzheimer's disease.
ebixa 5 mgpump actuation oral solution
lundbeck israel ltd. - memantine hydrochloride - drops - memantine hydrochloride 10 mg/g - memantine - memantine - treatment of patient with moderately to severe alzheimer's disease.
ebixa tablets 20 mg
lundbeck israel ltd. - memantine hydrochloride - film coated tablets - memantine hydrochloride 20 mg - memantine - memantine - treatment of patient with moderate to severe alzheimer's disease.
scabiex
rekah pharmaceutical industry ltd, israel - benzyl benzoate - emulsion - benzyl benzoate 25 % - benzyl benzoate - benzyl benzoate - treatment of scabies.
foster 1006
kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.copd :symptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
mizollen tablets 10 mg
pharma shalom - mizolastine - film coated tablets - mizolastine 10 mg - mizolastine - mizolastine - symptomatic treatment of seasonal allergic rhinoconjuctivitis (hay fever), perennial allergic rhino-conjuctivitis and urticaria.